(Q24194482)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25090020%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

meta-analysis

0 references

title

Topical antifungal treatments for tinea cruris and tinea corporis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25090020%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25090020%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Esther J van Zuuren

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25090020%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Liz Doney

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25090020%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Michael Moore

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25090020%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

author name string

Magdy El-Gohary

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25090020%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Hana Burgess

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25090020%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Beth Stuart

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25090020%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Paul Little

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25090020%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

language of work or name

English

0 references

publication date

4 August 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25090020%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

11 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25090020%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25090020%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

page(s)

CD009992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25090020%20AND%20SRC:MED&resulttype=core&format=json

Comparison of superficial mycosis treatment using Butenafine and Bifonazole nitrate clinical efficacy

11 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Comparative evaluation of effectivity and safety of topical amorolfine and clotrimazole in the treatment of tinea corporis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Comparative study of 2% sertaconazole solution and cream formulations in patients with tinea corporis, tinea pedis interdigitalis, or a corresponding candidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Terbinafine 1% cream vs. bifonazole 1% cream in the treatment of tinea cruris

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Comparison of clotrimazole cream, Whitfield's ointment and Nystatin ointment for the topical treatment of ringworm infections, pityriasis versicolor, erythrasma and candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

A clinical double-blind trial of topical haloprogin and miconazole against superficial fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

A clinical double-blind trial comparing amorolfine cream 0.5% (RO-14-4767) with bifonazole cream 1% in the treatment of dermatomycoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Topical treatment of tinea corporis and tinea cruris with eberconazole (WAS 2160) cream 1% and 2%: a phase II dose-finding pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

A double-blind randomized comparative trial: eberconazole 1% cream versus clotrimazole 1% cream twice daily in Candida and dermatophyte skin infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Efficacy of triclosan soap against superficial dermatomycoses: a double-blind clinical trial in 224 primary school-children in Kilombero District, Morogoro Region, Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Does naftifine have anti-inflammatory properties? A double-blind comparative study with 1% clotrimazole/1% hydrocortisone in clinically diagnosed fungal infection of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Short-duration therapy with terbinafine 1% cream in dermatophyte skin infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Sertaconazole 2% cream vs. miconazole 2% cream for cutaneous mycoses: a double-blind clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

A randomized trial to assess once-daily topical treatment of tinea corporis with butenafine, a new antifungal agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Comparative assessment of the efficacy and safety of sertaconazole (2%) cream versus terbinafine cream (1%) versus luliconazole (1%) cream in patients with dermatophytoses: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

A comparative study of once versus twice daily treatment of superficial dermatophyte and yeast infections with tioconazole (1%) cream

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Butenafine 1% cream in the treatment of tinea cruris: a multicenter, vehicle-controlled, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Sulconazole versus clotrimazole in the treatment of dermatophytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Double-blind comparison of amorolfine and bifonazole in the treatment of dermatomycoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Eberconazole 1% cream is an effective and safe alternative for dermatophytosis treatment: multicenter, randomized, double-blind, comparative trial with miconazole 2% cream

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Comparative efficacy of topical 1% butenafine and 1% clotrimazole in tinea cruris and tinea corporis: a randomized, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Dermatomycoses of the glabrous skin : a double-blind, randomised, comparative trial of sertaconazole 2% cream once daily versus vehicle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Tinea corporis/cruris: new treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Study to compare the efficacy and safety of fluconazole cream with flutrimazole cream in the treatment of superficial mycosis: a multicentre, randomised, double-blind, phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Efficacy of a 1-week, once-daily regimen of terbinafine 1% cream in the treatment of tinea cruris and tinea corporis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Effectiveness of body wipes as an adjunct to reducing skin infections in high school wrestlers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Naftifine cream 1% compared with miconazole cream 2% in dermatophytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

A comparative double blind study of ketoconazole and griseofulvin in dermatophytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Naftifine versus miconazole/hydrocortisone in inflammatory dermatophyte infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Flutrimazole 1% dermal cream in the treatment of dermatomycoses: a multicentre, double-blind, randomized, comparative clinical trial with bifonazole 1% cream. Efficacy of flutrimazole 1% dermal cream in dermatomycoses. Catalan Flutrimazole Study Gro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Efficacy and Safety of Terbinafine Hydrochloride 1% Cream vs. Sertaconazole Nitrate 2% Cream in Tinea Corporis and Tinea Cruris: A Comparative Therapeutic Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Treatment of superficial mycoses in the tropics: Whitfield's ointment versus clotrimazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

A comparative randomized open label study to evaluate efficacy, safety and cost effectiveness between topical 2% sertaconazole and topical 1% butenafine in tinea infections of skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Persistent and recurrent tinea corporis in children treated with combination antifungal/ corticosteroid agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Epidemiology of superficial fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Tinea cruris in routine urology practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Widespread, chronic, and fluconazole-resistant Trichophyton rubrum infection in an immunocompetent patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Epidemiological survey of dermatophytosis in Tehran, Iran, from 2000 to 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Oral treatments for fungal infections of the skin of the foot.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

How to formulate research recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Topical treatments for fungal infections of the skin and nails of the foot

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Meta-analysis combining parallel and cross-over clinical trials. II: Binary outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Terbinafine: a review of its use in onychomycosis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Topical antifungal treatments for tinea cruris and tinea corporis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Topical therapy for dermatophytoses: should corticosteroids be included?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Efficacy of topical antifungal agents in the treatment of dermatophytosis: an incomplete meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Systemic antifungal therapy for tinea capitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Clotrimazole/betamethasone diproprionate: a review of costs and complications in the treatment of common cutaneous fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

The structure-bioavailability approach in antifungal agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Tinea corporis, tinea cruris, tinea nigra, and piedra

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Optimal management of fungal infections of the skin, hair, and nails

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Update in antifungal therapy of dermatophytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Epidemiological trends in skin mycoses worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

The advantages of topical combination therapy in the treatment of inflammatory dermatomycoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Adjustment of meta-analyses on the basis of quality scores should be abandoned

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Emerging fungal infections among children: A review on its clinical manifestations, diagnosis, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Pharmaceutical industry sponsorship and research outcome and quality: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

The diagnosis and management of tinea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Scales to assess the quality of randomized controlled trials: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Efficacy and safety of topical antifungals in the treatment of dermatomycosis: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Efficacy of topical antifungals in the treatment of dermatophytosis: a mixed-treatment comparison meta-analysis involving 14 treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Updates on the epidemiology of dermatophyte infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

The susceptibility of dermatophytes to photodynamic treatment with special focus on Trichophyton rubrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Interventions for androgenic alopecia in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Efficacy and tolerability of sertaconazole nitrate 2% cream vs. miconazole in patients with cutaneous dermatophytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

Clotrimazole vs Haloprogin Treatment of Tinea Cruris

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

Synergistic effects of tetrandrine on the antifungal activity of topical ketoconazole cream in the treatment of dermatophytoses: a clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

Efficacy and tolerability of topical terbinafine in the treatment of tinea cruris.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

Treatment of tinea cruris with topical terbinafine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

Failure of clotrimazole-betamethasone dipropionate cream in treatment of Microsporum canis infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

Striae and persistent tinea corporis related to prolonged use of betamethasone dipropionate 0.05% cream/clotrimazole 1% cream (Lotrisone cream)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

Naftifine cream 1% versus econazole cream 1% in the treatment of tinea cruris and tinea corporis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

Guidelines of care for superficial mycotic infections of the skin: tinea corporis, tinea cruris, tinea faciei, tinea manuum, and tinea pedis. Guidelines/Outcomes Committee. American Academy of Dermatology

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

Nondermatologists are more likely than dermatologists to prescribe antifungal/corticosteroid products: an analysis of office visits for cutaneous fungal infections, 1990-1994

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

Topical treatment of dermatophytosis and cutaneous candidosis with flutrimazole 1% cream: double-blind, randomized comparative trial with ketoconazole 2% cream

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

Evaluation of the Effectiveness of Griseofulvin, Tolnaftate, and Placebo in the Topical Therapy of Superficial Dermatophytoses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

Ciclopirox: a new topical pyrodonium antimycotic agent. A double-blind study in superficial dermatomycoses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

A double-blind comparison of sulconazole nitrate 1% cream with clotrimazole 1% cream in the treatment of dermatophytoses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

Topical (1%) solution of griseofulvin in the treatment of tinea corporis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

A clinical double-blind trial of topical miconazole and clotrimazole against superficial fungal infections and erythrasma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

Double blind comparison of the efficacy of tioconazole and miconazole for the treatment of fungal infection of the skin or erythrasma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

Clinical efficacy of terbinafine in 629 Japanese patients with dermatomycosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

Dose-finding study of amorolfine cream (0.125%, 0.25% and 0.5%) in the treatment of dermatomycoses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

A new topical antifungal drug: tioconazole

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

Double-blind randomized comparative study of naftifine cream and clotrimazole cream in the treatment of dermatophytosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

Once-daily naftifine cream 1% in the treatment of tinea cruris and tinea corporis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

Naftifine treatment for dermatophytosis: multicenter clinical investigations in Turkey. Turkish Multicenter Dermatophytosis Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

Dermatophyte infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

Double-blind comparison of miconazole/corticosteroid combination versus miconazole in inflammatory dermatomycoses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

Topical Antimycotic Agents for the Treatment of Superficial Dermatophytoses in Thailand -A Double-Blind Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

Comparison of oxiconazole (Ro 13-8996) and econazole in dermatomycoses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

Flutrimazole 1% dermal cream in the treatment of dermatomycoses: a randomized, multicentre, double-blind, comparative clinical trial with 1% clotrimazole cream. Flutrimazole Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

Bizarre annular lesion emerging as tinea incognito

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

1 reference

7 January 2021

Fenticonazole cream once daily in dermatomycosis, a double-blind controlled trial versus bifonazole

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

One daily application of oxiconazole cream is sufficient for treating dermatomycoses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

Double-Blind Comparison of the Efficacy, Toleration and Safety of Tioconazole Base 1% and Econazole Nitrate 1% Creams in the Treatment of Patients with Fungal Infections of the Skin or Erythrasma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

A double-blind study comparing Daktacort, miconazole and hydrocortisone in inflammatory skin infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

Tolciclate versus miconazole, a double-blind trial in patients with dermatomycosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

Multicentre double-blind clinical trials of ciclopirox olamine cream 1% in the treatment of tinea corporis and tinea cruris

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

Effect of fenticonazole spray in cutaneous mycosis: a double-blind clinical trial versus cyclopyroxolamine spray

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

Clinical evaluation of fenticonazole cream in cutaneous fungal infections: a comparison with miconazole cream

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

A double-blind clinical trial of fenticonazole (2%) spray versus naftifine (1%) spray in patients with cutaneous mycoses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009992.PUB2

7 January 2021

10.1002/14651858.CD009992.PUB2

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

3371496

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25090020%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

3371496

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

2 references

3371496

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25090020%20AND%20SRC:MED&resulttype=core&format=json